National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1225064

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1225064
VAERS Form:2
Age:
Sex:Male
Location:Foreign
Vaccinated:2021-02-22
Onset:2021-02-23
Submitted:0000-00-00
Entered:2021-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6790 / UNK - / -

Administered by: Other      Purchased by: ??
Symptoms: Death, Dizziness, Nausea, Mobility decreased, General physical health deterioration, Poor quality sleep

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-03-09
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LINATIL; ELIQUIS; HUMIDOSE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anticoagulant therapy; Cardiac pacemaker insertion (insertion of a permanent VV1 pacemaker); Gallstones removal (gallstone removal, monitored from 2002 onwards); Hypertension
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': FIPFIZER INC2021398633

Write-up: Unknown cause of death; Mobility decreased; Sleep restless; Nausea; Dizziness; General physical health deterioration; This is a spontaneous report from a contactable consumer downloaded from a regulatory authority-WEB, regulatory authority number FI-FIMEA-20211659. An 88-year-old male patient received BNT162B2 (COMIRNATY), via an unspecified route of administration on 22Feb2021 (Batch/Lot Number: EJ6790) as single dose for COVID-19 immunisation. Medical history included VV1 pacemaker (cardiac pacemaker insertion) on 31Jan2020: insertion of a permanent VV1 pacemaker, gallstone removal from the beginning of 2020: "monitored from 2002 onwards", hypertension and anticoagulant therapy. Concomitant medications included enalapril maleate (LINATIL) taken for hypertension, start and stop date were not reported; apixaban (ELIQUIS) taken for anticoagulant therapy, start and stop date were not reported; calcium chloride dihydrate, potassium chloride, sodium chloride (HUMIDOSE) taken for an unspecified indication, start and stop date were not reported. On 23Feb2021, the patient experienced mobility decreased, sleep restless, nausea, dizziness and general physical health deterioration. The day after the vaccination there was difficulty moving due to dizziness, he had to take support from the walls while walking and had nausea and restless sleep. On 09Mar2021, he had difficulty getting out of bed. His overall condition deteriorated after vaccination. The patient died (unknown cause of death) on 09Mar2021. The results of the forensic autopsy research were not yet available. No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Unknown cause of death

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1225064&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166